Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Consistent Delivery: Provides steady, sustained peptide delivery to target tissues
Over the years, research and development have improved the reliability and affordability of this technology, making it more accessible
A quick consultation helps us tailor the best plan for your energy and weight management goals
Zinc is also found in pancreatic beta cells and helps regulate insulin synthesis, storage, and release, which supports healthy blood sugar levels